Roy P, Banik D, Chowdhury F, Bakar Siddique MA. Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. World J Oncol [Internet]. 2026 Jan. 1 [cited 2026 Sep. 5];17(5):599-613. Available from: https://wjon.elmerpub.com/wjon/article/view/2842